SCHEMBL14508169

SCHEMBL14508169

CC1(C)c2cc(-c3cccc(-c4ccccn4)c3)ccc2-c2ccc(-c3cccc(-c4ccccn4)c3)cc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 3/20 0.52
CYP2A6 P11509 1/20 0.41
HTR1A P08908 1/20 0.40
HTR7 P34969 1/20 0.40
TLR4 O00206 1/20 0.40
TLR2 O60603 1/20 0.40
KDM4E B2RXH2 3/20 0.39
LMNA P02545 2/20 0.39
CCR1 P32246 2/20 0.39
CCR5 P51681 2/20 0.39
CCR8 P51685 2/20 0.39
CYP1A2 P05177 2/20 0.39
POLB P06746 1/20 0.39
METAP1 P53582 1/20 0.39
BLM P54132 1/20 0.39
HIF1A Q16665 1/20 0.39
DOHH Q9BU89 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
BACE1 P56817 2/20 0.39
NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14508269 0.98 PDK2 (0.51) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508280 0.98 PDK2 (0.51) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508222 0.97 PDK2 (0.50) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508205 0.97 PDK2 (0.50) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508210 0.97 PDK2 (0.50) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508209 0.96 PDK2 (0.56) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508229 0.96 PDK2 (0.56) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508133 0.96 PDK2 (0.56) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508140 0.96 PDK2 (0.56) PDK2CYP2A6HTR1AHTR7TLR4
SCHEMBL14508225 0.94 PDK2 (0.50) PDK2CYP2A6HTR1AHTR7KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 PDK2 3230/4885CYP2A6 3090/4885HTR1A 2578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.